## Abstract The impact of erythropoiesis‐stimulating agent (ESA) on cancer patients' survival has recently become a matter of extensive discussion. Studies in solid tumors demonstrated that ESA adversely affects survival. This issue has not been sufficiently studied in patients with multiple myelom
Overexpression of cyclooxygenase-2 in multiple myeloma: Association with reduced survival
✍ Scribed by Mustafa Cetin; Suleyman Buyukberber; Muzaffer Demir; Ismail Sari; Ibrahim Sari; Kemal Deniz; Bulent Eser; Fevzi Altuntas; Celalettin Camcı; Ahmet Öztürk; Burhan Turgut; Özden Vural; Ali Unal
- Publisher
- John Wiley and Sons
- Year
- 2005
- Tongue
- English
- Weight
- 118 KB
- Volume
- 80
- Category
- Article
- ISSN
- 0361-8609
No coin nor oath required. For personal study only.
📜 SIMILAR VOLUMES
Overexpression of cyclooxygenase-2 (COX-2) has been reported in gastric cancers. However, the relationship between expression of COX-2 and clinico-pathological or genotypic features has not been elucidated. To address the issue, expression of COX-2 protein was analyzed in 100 gastric cancers as well
The causes of multiple myeloma (MM) are obscure, but a laboratory association was recently reported between MM and human herpesvirus 8 (HHV-8), the probable etiologic agent of Kaposi's sarcoma (KS). Although there has been some additional laboratory corroboration, most laboratory studies have found
antibodies, the authors immunostained sections of formalin fixed, paraffin embedded tissues from 289 Stage I NSCLCs. The Kaplan-Meier survival method, the log Department of Pathology, Baylor College of rank test, and Fisher's exact test were used for statistical analysis. Medicine and the Methodist